Excretion of gonadotrophins during gestagen- and oestrogen-treatment. The excretion of total pituitary gonadotrophins in menopausal and oophorectomized women during treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone and 17-alpha-ethynyl-oestradiol-3-methylether respectively.
D000328:Adult; D002369:Castration; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D008535:Megestrol / Q000494:pharmacology / Q000627:therapeutic use; D008593:Menopause; D008656:Mestranol / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D011372:Progestins / Q000494:pharmacology*
D003276:Contraceptives, Oral; D006065:Gonadotropins, Pituitary; D011372:Progestins; D008656:Mestranol; D008535:Megestrol